Version 5.4
Mus musculus Protein: Pdcd2l
Summary
InnateDB Protein IDBP-173212.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Pdcd2l
Protein Name programmed cell death 2-like
Synonyms 6030457N17Rik;
Species Mus musculus
Ensembl Protein ENSMUSP00000002710
InnateDB Gene IDBG-173210 (Pdcd2l)
Protein Structure
UniProt Annotation
Function Over-expression suppresses AP1, CREB, NFAT, and NF-kB transcriptional activation, and delays cell cycle progression at S phase. {ECO:0000250}.
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
Predicted by orthology
Total 2 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003674 molecular_function
Biological Process
GO:0007049 cell cycle
GO:0008150 biological_process
Cellular Component
GO:0005575 cellular_component
GO:0005737 cytoplasm
GO:0016020 membrane
Protein Structure and Domains
PDB ID MGI:1915329
InterPro IPR007320 Programmed cell death protein 2, C-terminal
PFAM PF04194
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q8C5N5
PhosphoSite PhosphoSite-Q8C5N5
TrEMBL
UniProt Splice Variant
Entrez Gene 68079
UniGene Mm.473980
RefSeq NP_080825
MGI ID
MGI Symbol Pdcd2l
OMIM
CCDS CCDS21137
HPRD
IMGT
EMBL AK003339 AK077948 AK151495 AK154811 BC025090 BC115797
GenPept AAH25090 AAI15798 BAB22726 BAC37080 BAE30447 BAE32845

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca